Article
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.
Advances in therapy - 1 Aug 2020
Zubiaur Pablo, Saiz-Rodríguez Miriam, Ochoa Dolores, Navares-Gómez Marcos, Mejía Gina, Román Manuel, Koller Dora, Soria-Chacartegui Paula, Almenara Susana, Abad-Santos Francisco
Abstract excerpt
INTRODUCTION: Dabigatran is a direct oral anticoagulant (DOAC) used for the treatment of several thrombotic conditions. To date, very few pharmacogenetic studies on dabigatran were published. We aimed to investigate the influence of 59 polymorphisms in 15 genes (including CES1, UGT and CYP that encode enzymes and ABCB1 and SLC that encode transporters), concomitant treatment with pantoprazole and demographic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
